MENU
+Compare
AXGN
Stock ticker: NASDAQ
AS OF
Nov 20, 04:59 PM (EDT)
Price
$25.68
Change
+$0.42 (+1.66%)
Capitalization
1.18B

AXGN stock forecast, quote, news & analysis

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair... Show more

AXGN
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AXGN showed earnings on October 29, 2025. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for AXGN with price predictions
Nov 19, 2025

AXGN saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for AXGN moved out of overbought territory on November 14, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 52 similar instances where the indicator exited the overbought zone. In of the 52 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Moving Average Convergence Divergence Histogram (MACD) for AXGN turned negative on November 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AXGN broke above its upper Bollinger Band on November 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2025. You may want to consider a long position or call options on AXGN as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

AXGN moved above its 50-day moving average on October 16, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 224 cases where AXGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.643) is normal, around the industry mean (62.926). P/E Ratio (0.000) is within average values for comparable stocks, (35.899). AXGN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.667). AXGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (5.408) is also within normal values, averaging (84.432).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Dividends

AXGN paid dividends on February 12, 2010

Axogen AXGN Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of February 12, 2010, and an ex-dividend date of January 27, 2010. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.58B. The market cap for tickers in the group ranges from 1.86K to 215.57B. ABT holds the highest valuation in this group at 215.57B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -5%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was 8%. MCRXF experienced the highest price growth at 75%, while FZMD experienced the biggest fall at -60%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was 8% and the average quarterly volume growth was 29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 74
Price Growth Rating: 64
SMR Rating: 86
Profit Risk Rating: 93
Seasonality Score: 15 (-100 ... +100)
View a ticker or compare two or three
AXGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of products and technologies for peripheral nerve reconstruction and regeneration

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
13631 Progress Boulevard
Phone
+1 386 462-6800
Employees
428
Web
https://www.axogeninc.com